March 16th, 2022
•This protocol describes using commercial, cell-free protein expression kits to produce membrane proteins supported in nanodisc that can be used as antigens in subunit vaccines.
Related Videos
Recombinant Retroviral Production and Infection of B Cells
Production and Titering of Recombinant Adeno-associated Viral Vectors
Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
Forward Genetic Approaches in Chlamydia trachomatis
Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
Using Click Chemistry to Measure the Effect of Viral Infection on Host-Cell RNA Synthesis
In Vitro Analysis of Myd88-mediated Cellular Immune Response to West Nile Virus Mutant Strain Infection
Legionella pneumophila Outer Membrane Vesicles: Isolation and Analysis of Their Pro-inflammatory Potential on Macrophages
Single-cell Quantitation of mRNA and Surface Protein Expression in Simian Immunodeficiency Virus-infected CD4+ T Cells Isolated from Rhesus macaques
Separation of the Cell Envelope for Gram-negative Bacteria into Inner and Outer Membrane Fractions with Technical Adjustments for Acinetobacter baumannii
Copyright © 2024 MyJoVE Corporation. 판권 소유